Akira Sekikawa

• University of Pittsburgh at Pittsburgh

  Professor

Sources: reporter.nih.gov

• National Institute on Aging

  R01, Arterial Stiffness, Cognition, and Equol (ACE), R01AG074971, 2022–2027, 24 Jul 2026

• National Heart, Lung, and Blood Institute

  R01, Integrative Model of Metabolomics, Equol and Atherosclerotic cardiovascular disease (IMMEA), R01HL169332, 2024–2028, 7 Jul 2026

• National Institute of Arthritis and Musculoskeletal and Skin Diseases

  R01, Effects of Equol, the most bioactive soy isoflavone, on bone microarchitecture, density, strength and turnover, R01AR085928, 2026–2030, 30 Jun 2026

• National Institute on Aging

  R01, 7T Vascular and Molecular Imaging of SVD: Sex, Equol, and Risk of Alzheimer’s Disease, R01AG085566, 2024–2029, 19 Jun 2026

• National Heart, Lung, and Blood Institute

  T32, Cardiovascular Epidemiology Training Program, T32HL083825, 2008–2029, 20 Mar 2026

Sources: reporter.nih.gov